Serum Nitric Oxide metabolites and high sensitivity C-reactive protein are important biomarkers In non obese, indian type 2 diabetic males

International Journal of Diabetes in Developing Countries

Volumn 32, Issue 3, 2012, Pages 163-168

  Sarangi, Rajlaxmi ^a,b   Padhi, Somanath ^a   Mahapatra, Srikrushna ^b   Bhumika, Nateshan ^a  

^a PONDICHERRY INSTITUTE OF MEDICAL SCIENCES   (India)

^b Maharaja Krushna Chandra Gajapati Medical College and Hospital   (India)

Author keywords

Hs CRP; Hypertension; Nitric Oxide metabolites; Retinopathy; Type 2diabetes mellitus

Indexed keywords

EID: 84866280166     PISSN: 09733930     EISSN: 19983832     Source Type: Journal    
DOI: 10.1007/s13410-012-0084-0     Document Type: Article

References (27)

1. Pitocco D, Zaccardi F, Di Stasio E, Romitelli F, Santini SA, Zuppi C, et al. Oxidative stress, nitric oxide, and diabetes. Rev Diabet Stud. 2010;7:15-25.
2. Goycheva P, Gadjeva V, Popov V. Oxidative stress and its complications in diabetes mellitus. Trakia J Sci. 2006;4:1-8.
3. Abou-Seif MA, Youssef AA. Evaluation of some biochemical changes in diabetic patients. Clin Chim Acta. 2004;346:161-70.
4. Lee S, Kim IT, Park HB, Hyun YK, Kim YJ, Sung SO, Kim H. High-sensitivity C-reactive protein can predict major adverse cardiovascular events in Korean patients with type 2 diabetes. J Korean Med Sci. 2011;26:1322-7.
5. Wen J, Liang Y, Wang F, Sun L, Guo Y, Duan X, et al. C reactive protein, gamma-glutamyltransferase and type 2 diabetes in a Chinese population. Clin Chim Acta. 2010;411:198-203.
6. Bruno G, Fornengo P, Novelli G, Panero F, Perotto M, Segre O, et al. C-reactive protein and 5-year survival in type 2 diabetes: the Casale Monferrato Study. Diabetes. 2009;58:926-33.
7. Kang ES, Kim HJ, Ahn CW, Park CW, Cha BS, Lim SK, Kim KR, Lee HC. Relationship of serum high sensitivity C-reactive protein to metabolic syndrome and microvascular complications in type 2 diabetes. Diabetes Res Clin Pract. 2005;69:151-9.
8. Vikram NK, Misra A, Pandey RM, Dwivedi M, Luthra K, Dhingra V, et al. Association between subclinical inflammation & fasting insulin in urban young adult north Indian males. Indian J Med Res. 2006;124:677-82.
9. Zhang W, Liu H, Al-Shabrawey M, Caldwell RW, Caldwell RB. Inflammation and diabetic retinal microvascular complication. J Cardiovasc Dis Res. 2011;2:96-103.
10. Ghose A, Sherpa ML, Bhutia Y, Pal R, Dahal S. Serum nitric oxide status in patients with type 2 diabetes mellitus in Sikkim. Int J App Basic Med Res. 2011;1:31-5.
11. Toutouzas K, Riga M, Stefanadi E, Stefanadis C. Asymmetric dimethylarginine (ADMA) and other endogenous nitric oxide synthase (NOS) inhibitors as an important cause of vascular insulin resistance. Horm Metab Res. 2008;40:655-9.
12. Ayub SG, Ayub T, Khan SN, Dar R, Andrabi KI. Reduced nitrate level in individuals with hypertension and diabetes. J Cardiovasc Dis Res. 2011;2:172-6.
13. American Diabetes Association. Standards of medical care in diabetes-2011. Diabetes Care. 2011;34 Suppl 1:S11-61.
14. Bryan NS, Grisham MB. Methods to detect nitric oxide and its metabolite in biological samples. Free Radic Biol Med. 2007;43:645-57.
15. Shahid SM, Mahboob T. Correlation between Glycosylated Hemoglobin (HbA1c) and Serum Nitric Oxide (NO). Aust J Basic Appl Sci. 2009;3:1323-7.
16. Lyamina NP, Dolotovskaya PV, Lyamina SV, Malyshev IY, Manukhina EB. Nitric oxide production and intensity of free radical processes in young men with high normal and hypertensive blood pressure. Med Sci Monit. 2003;9:CR304-10.
17. Takase H, Sugiyama M, Nakazawa A, Sato K, Ueda R, Dohi Y. Long-term effect of antihypertensive therapy with calcium antagonist or angiotensin converting enzyme inhibitor on serum nitrite/nitrate levels in human essential hypertension. Arzneimittelforschung. 2000;50:530-4.
18. Li R, Lyn D, Lapu-Bula R, Oduwole A, Igho-Pemu P, Lankford B, et al. Relation of endothelial nitric oxide synthase gene to plasma nitric oxide level, endothelial function and blood pressure in African Americans. Am J Hypertens. 2004;17:560-7.
19. Khan MA. Nitric oxide and lipid peroxidation status in diabetes mellitus and hypertension. PhD thesis, University of Karachi, Karachi. ID Code: 1134.
20. Ozden S, Tatlipinar S, Biçer N, Yaylali V, Yildirim C, Ozbay D, et al. Basal serum nitric oxide levels in patients with type 2 diabetes mellitus and different stages of retinopathy. Can J Ophthalmol. 2003;38:393-6.
21. Apakkan S, Ozmen B, Ozmen D, Parildar Z, Senol B, Habif S, et al. Serum and urinary nitric oxide in type 2 diabetes with or without microalbuminuria: relation to glomerular hyperfiltration. J Diabetes Complicat. 2003;17:343-8.
22. Izumi N, Nagaoka T, Mori F, Sato E, Takahashi A, Yoshida A. Relation between plasma nitric oxide levels and diabetic retinopathy. Jpn J Ophthalmol. 2006;50:465-8.
23. Asl SZ, Ghasemi A, Azizi F. Serum nitric oxide metabolites in subjects with metabolic syndrome. Clin Biochem. 2008;41:1342-97.
24. Tsai DC, Chiou SH, Lee FL, Chou CK, Chen SJ, Peng CH, et al. Possible involvement of nitric oxide in the progression of diabetic retinopathy. Ophthalmologica. 2003;217:342-6.
25. Lim LS, Tai ES, Mitchell P, et al. C-reactive protein, body mass index, and diabetic retinopathy. Invest Ophthalmol Vis Sci. 2010;51:4458-63.
26. Tsunoda K, Arita M, Yukawa M, et al. Retinopathy and hypertension affect serum high-sensitivity C-reactive protein levels in type 2 diabetic patients. J Diabetes Complications. 2005;19:123-7.
27. Liou GI. Diabetic retinopathy: role of inflammation and potential therapies for anti-inflammation. World J Diabetes. 2010;1:12-8.